gavin
Topics Engaged In
-
- Topic
- Voices
- Last Post
-
- Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Pa
- 1
- 4 years, 9 months ago
- Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With
- 1
- 4 years, 9 months ago
- A Single Arm Phase II Study of the Combination of DKN-01 and Nivolumab in Previo
- 1
- 4 years, 9 months ago
- Predictive Factors and Microbial Spectrum for Infectious Complications after Hep
- 1
- 4 years, 9 months ago
- Management implications of fluorodeoxyglucose positron emission tomography/magne
- 1
- 4 years, 9 months ago
- PTPN3 suppresses the proliferation and correlates with favorable prognosis of pe
- 1
- 4 years, 9 months ago
- A case of small in situ perihilar cholangiocarcinoma incidentally accompanied by
- 1
- 4 years, 9 months ago
- Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurr
- 1
- 4 years, 9 months ago
- Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors Phase II, m
- 1
- 4 years, 9 months ago
- STARTRK-2: An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectini
- 1
- 4 years, 9 months ago
- My Pathway: An Open Label Phase IIa Study Evaluating Trastuzumab/Pertuzumab, Erl
- 1
- 4 years, 9 months ago